Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Adami

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Aging Clinical and Experimental Research|November 4, 2022
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis settingAngelo Fassio, Stefano Andreola, Davide Gatti, et al.
Nutrients|May 31, 2020
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label StudyAngelo Fassio, Giovanni Adami, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|November 28, 2022
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosisRiccardo Bixio, Giovanni Adami, Eugenia Bertoldo, et al.
The Journal of Investigative Dermatology|April 10, 2025
Environmental Exposure to Particulate Matter 10 and Mycosis Fungoides: No Evidence of Increased RiskFrancesco Bellinato, Giovanni Adami, Maria Antonietta Reatini, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 6, 2026
Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone lossFederico Aldegheri, Angelo Fassio, Matteo Appoloni, et al.
Therapeutic Advances in Musculoskeletal Disease|July 5, 2022
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort studyGiovanni Adami, Irene Gavioli, Maurizio Rossini, et al.
JBMR Plus|March 28, 2024
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational studyGiovanni Adami, Elisa Pedrollo, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|April 28, 2026
Bone metabolism and inflammation drive structural damage in rheumatoid arthritis: clustering and multivariable analysisFrancesco Pollastri, Ombretta Viapiana, Davide Gatti, et al.
Annals of the Rheumatic Diseases|February 24, 2026
Seasonality of IgG4-related diseaseMaria-Elena Corona, Giovanni Adami, Maria Antonietta Reatini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 17, 2025
Impact of particulate matter exposure on melanoma risk: A multicentre case-control studyFrancesco Bellinato, Giovanni Adami, Maria Antonietta Reatini, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Aging Clinical and Experimental Research|November 4, 2022
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis settingAngelo Fassio, Stefano Andreola, Davide Gatti, et al.
Nutrients|May 31, 2020
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label StudyAngelo Fassio, Giovanni Adami, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|November 28, 2022
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosisRiccardo Bixio, Giovanni Adami, Eugenia Bertoldo, et al.
The Journal of Investigative Dermatology|April 10, 2025
Environmental Exposure to Particulate Matter 10 and Mycosis Fungoides: No Evidence of Increased RiskFrancesco Bellinato, Giovanni Adami, Maria Antonietta Reatini, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 6, 2026
Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone lossFederico Aldegheri, Angelo Fassio, Matteo Appoloni, et al.
Therapeutic Advances in Musculoskeletal Disease|July 5, 2022
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort studyGiovanni Adami, Irene Gavioli, Maurizio Rossini, et al.
JBMR Plus|March 28, 2024
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational studyGiovanni Adami, Elisa Pedrollo, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|April 28, 2026
Bone metabolism and inflammation drive structural damage in rheumatoid arthritis: clustering and multivariable analysisFrancesco Pollastri, Ombretta Viapiana, Davide Gatti, et al.
Annals of the Rheumatic Diseases|February 24, 2026
Seasonality of IgG4-related diseaseMaria-Elena Corona, Giovanni Adami, Maria Antonietta Reatini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 17, 2025
Impact of particulate matter exposure on melanoma risk: A multicentre case-control studyFrancesco Bellinato, Giovanni Adami, Maria Antonietta Reatini, et al.
Pageof 15